Loading market dashboard
Calliditas Therapeutics AB (publ)
CALTHealthcareNASDAQSE
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Calliditas Therapeutics AB (publ) · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $7.59B | $7.59B - $7.59B | -$4.50B | $154.40 | 1 |
| Dec 2027 | $6.09B | $6.09B - $6.09B | -$3.62B | $112.29 | 1 |
| Dec 2026 | $4.59B | $4.59B - $4.59B | -$2.73B | $71.949 | 2 |
| Dec 2025 | $3.31B | $2.75B - $4.34B | -$1.97B | $40.082 | 3 |
| Dec 2024 | $2.26B | $2.12B - $2.36B | -$1.34B | -$2.013 | 3 |
| Dec 2023 | $1.09B | $1.03B - $1.15B | -$644.88M | -$13.416 | 5 |
| Dec 2022 | $641.24M | $547.30M - $810.89M | -$380.42M | -$14.396 | 2 |
| Dec 2021 | $217.94M | $189.20M - $267.27M | -$129.29M | -$15.549 | 3 |
| Dec 2020 | $207.0K | $179.7K - $253.8K | -$122.8K | -$10.835 | 3 |
| Dec 2019 | $222.72M | $193.35M - $273.13M | -$132.13M | -$1.643 | 2 |